These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7835918)

  • 21. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
    Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs.
    Bouwer HG; Seaman MS; Forman J; Hinrichs DJ
    J Immunol; 1997 Sep; 159(6):2795-801. PubMed ID: 9300701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
    Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of antigen processing and presentation molecules in West Nile virus-infected human skin fibroblasts.
    Arnold SJ; Osvath SR; Hall RA; King NJ; Sedger LM
    Virology; 2004 Jul; 324(2):286-96. PubMed ID: 15207616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection.
    King NJ; Kesson AM
    J Gen Virol; 1988 Oct; 69 ( Pt 10)():2535-43. PubMed ID: 2844965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system.
    Liu Y; Blanden RV; Müllbacher A
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():565-73. PubMed ID: 2543751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of immune recognition molecules by flavivirus, West Nile.
    Kesson AM; Cheng Y; King NJ
    Viral Immunol; 2002; 15(2):273-83. PubMed ID: 12081012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of West Nile virus on major histocompatibility complex class I and II molecule expression by Lewis rat Schwann cells in vitro.
    Argall KG; Armati PJ; King NJ; Douglas MW
    J Neuroimmunol; 1991 Dec; 35(1-3):273-84. PubMed ID: 1955569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro.
    Liu Y; King N; Kesson A; Blanden RV; Müllbacher A
    Ann N Y Acad Sci; 1988; 540():483-5. PubMed ID: 2849899
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells.
    King NJ; Maxwell LE; Kesson AM
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):911-5. PubMed ID: 2492666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flavivirus induces MHC antigen on human myoblasts: a model of autoimmune myositis?
    Bao S; King NJ; Dos Remedios CG
    Muscle Nerve; 1992 Nov; 15(11):1271-7. PubMed ID: 1488065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development.
    M S Barron A; Fabre T; De S
    F1000Res; 2024; 13():54. PubMed ID: 38681509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus.
    Khan MT; Islam R; Jerin TJ; Mahmud A; Khatun S; Kobir A; Islam MN; Akter A; Mondal SI
    PLoS One; 2021; 16(6):e0253393. PubMed ID: 34138958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF1R antagonism limits local restimulation of antiviral CD8
    Funk KE; Klein RS
    J Neuroinflammation; 2019 Jan; 16(1):22. PubMed ID: 30704498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A theoretical model of the West Nile Virus survival data.
    Peterson JK; Kesson AM; King NJC
    BMC Immunol; 2017 Jun; 18(Suppl 1):22. PubMed ID: 28681706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells.
    Wen L; Zhu M; Madigan MC; You J; King NJ; Billson FA; McClellan K; Sutton G; Petsoglou C
    PLoS One; 2014; 9(7):e101841. PubMed ID: 25003339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. West Nile Virus: biology, transmission, and human infection.
    Colpitts TM; Conway MJ; Montgomery RR; Fikrig E
    Clin Microbiol Rev; 2012 Oct; 25(4):635-48. PubMed ID: 23034323
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.